Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Medicover AB ( ($SE:MCOV.B) ) has issued an update.
Medicover AB has had its greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi). The company aims to significantly reduce its scope 1, 2, and 3 emissions by 2030 and 2050, aligning with its goal of achieving net zero emissions by 2050. This commitment underscores Medicover’s dedication to sustainability while expanding its healthcare services.
The most recent analyst rating on ($SE:MCOV.B) stock is a Hold with a SEK281.00 price target. To see the full list of analyst forecasts on Medicover AB stock, see the SE:MCOV.B Stock Forecast page.
More about Medicover AB
Medicover is a leading international healthcare and diagnostic services company, founded in 1995. It operates ambulatory clinics, hospitals, laboratories, and specialty-care facilities, with major markets in Poland, Germany, Romania, and India. In 2024, the company reported revenues of EUR 2,092 million and employed over 47,000 people.
Average Trading Volume: 84,532
Technical Sentiment Signal: Buy
Current Market Cap: SEK39.25B
For an in-depth examination of MCOV.B stock, go to TipRanks’ Overview page.